Back

Impaired cardiac cell phenotype in fabry disease using induced pluripotent stem cell-derived cardiomyocytes

30 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Cardiac remodeling and multiorgan interactions in heart failure Cardiac Biology and Physiology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Fahimeh Varzideh

New York (United States of America)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Mr R. Miyamoto (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Associate Professor S. Usui (Kanazawa, JP)
Abstract
Presentation thumbnail
Doctor Y. Devaux (Luxembourg, LU)
Abstract Slides Video
Presentation thumbnail
Doctor K. Jin (Wuhan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Cardiac remodeling and multiorgan interactions in heart failure

The Event

Event poster

ESC Congress 2025

30 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
CRISPR/Cas9-mediated GLA gene editing in human iPSC-derived ventricular cardiomyocytes as a model of Fabry cardiomyopathy
31 August 2026
thumbnail
Congress Presentation
New clinical staging proposal applied to a Fabry cardiomyopathy cohort
1 September 2024
thumbnail
Congress Presentation
Fabry cardiomyopathy: myocardial fibrosis, inflammation and reduced mannose6phosphate receptors cause low accessibility to enzyme therapy.
2 September 2024
thumbnail
Congress Presentation
First time evaluation of myocardium microRNA profile in Anderson-Fabry disease: implications in the pathological processes
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources